Page last updated: 2024-09-05

stronger neominophagen c and glycyrrhizic acid

stronger neominophagen c has been researched along with glycyrrhizic acid in 4 studies

Compound Research Comparison

Studies
(stronger neominophagen c)
Trials
(stronger neominophagen c)
Recent Studies (post-2010)
(stronger neominophagen c)
Studies
(glycyrrhizic acid)
Trials
(glycyrrhizic acid)
Recent Studies (post-2010) (glycyrrhizic acid)
18282,079701,068

Protein Interaction Comparison

ProteinTaxonomystronger neominophagen c (IC50)glycyrrhizic acid (IC50)
Corticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)0.0115
Corticosteroid 11-beta-dehydrogenase isozyme 1Mus musculus (house mouse)0.0135
Corticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)0.0007

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, M; Miura, M; Miyazaki, Y; Takahashi, T; Toyota, T; Ueno, Y; Yamamoto, T1
Furutani, T; Gondo, T; Hidaka, I; Hino, K; Kawano, H; Korenaga, M; Nishina, S; Sakai, A; Sakaida, I; Shinozaki, A1
Rino, Y; Yamamoto, N; Yukawa, N1
Horikiri, T; Kaneko, Y; Kinoshita, A; Kurita, Y; Kuwano, K; Odashima, K; Saito, Z; Seki, A; Seki, Y; Takeda, H; Yoshii, Y1

Reviews

1 review(s) available for stronger neominophagen c and glycyrrhizic acid

ArticleYear
Does herbal medicine reduce the risk of hepatocellular carcinoma?
    World journal of gastroenterology, 2015, Oct-07, Volume: 21, Issue:37

    Topics: Animals; Anti-Inflammatory Agents; Benzimidazoles; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drugs, Chinese Herbal; Fatty Liver; Fluorenes; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Preparations; Sofosbuvir; Tablets

2015

Other Studies

3 other study(ies) available for stronger neominophagen c and glycyrrhizic acid

ArticleYear
A case of drug-induced ductopenia resulting in fatal biliary cirrhosis.
    Liver, 1993, Volume: 13, Issue:4

    Topics: Bile Duct Diseases; Bile Ducts, Intrahepatic; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Liver; Liver Cirrhosis, Biliary; Middle Aged; Rhinitis, Allergic, Seasonal

1993
A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31, Issue:4

    Topics: Animals; Cysteine; DNA Primers; Dose-Response Relationship, Drug; Drug Combinations; Fatty Liver; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Immunoblotting; Iron; Iron, Dietary; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Transmission; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Statistics, Nonparametric; Sterol Regulatory Element Binding Protein 1

2011
Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis.
    BMC infectious diseases, 2016, Nov-11, Volume: 16, Issue:1

    Topics: Adult; Aged; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Liver; Male; Middle Aged; Retrospective Studies; Risk Factors; Tuberculosis; Ursodeoxycholic Acid; Young Adult

2016